ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullish•Hyundai Mobis
•09 Aug 2018 08:05

Hyundai Motor Group Restructuring Update - Revised Plan Summary

We had another interesting day yesterday. Samsung made a headline with its jaw-dropping investment size (a total ₩180tril). Samsung Biologics Co.,...

Logo
550 Views
Share
bullish•Samsung SDS
•08 Aug 2018 15:51

Samsung Group Plans to Invest 180 Trillion Won in the Next Three Years

The Samsung Group announced a major plan today to invest 180 trillion won (about US$160 billion) in the next three years, including in major...

Logo
453 Views
Share
bearish•Celltrion Inc
•08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Share
bullish•SK Inc
•14 Jul 2018 10:38

SK Holdings (034730 KS): AMPAC Acquisition - Summary & Ramifications

SK Holdings Co Ltd (034730 KS) said in a regulatory filing that it had acquired a 100% stake in Fine Chemicals Holdings Corp. which is the parent...

Logo
824 Views
Share
bullish•Samsung Biologics
•13 Jul 2018 01:56

Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications

This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...

Logo
956 Views
Share
x